Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pellegrino Musto

Showing results (1-10 of 392) with videos related to

Pageof 40
Sort By:
Clinical Lymphoma|January 11, 2003
Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple associationPellegrino Musto
Leukemia Research|April 28, 2004
Thalidomide therapy for myelodysplastic syndromes: current status and future perspectivesPellegrino Musto
Expert Opinion on Investigational Drugs|August 24, 2007
Melphalan: old and new uses of a still master drug for multiple myelomaPellegrino Musto, Fiorella D'Auria
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|February 8, 2024
A stable and sensitive 2D SERS sensor for bioanalytical applicationsMarianna Pannico, Pellegrino Musto
Expert Opinion on Biological Therapy|March 10, 2011
The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disordersPellegrino Musto, Fiorella D'Auria
Expert Review of Hematology|June 9, 2016
Are maintenance and continuous therapies indicated for every patient with multiple myeloma?Pellegrino Musto, Vittorio Montefusco
Expert Review of Hematology|March 11, 2020
Monoclonal antibodies in relapsed/refractory myeloma: updated evidence from clinical trials, real-life studies, and meta-analysesPellegrino Musto, Francesco La Rocca
Expert Review of Hematology|April 16, 2020
Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidencePellegrino Musto, Francesco La Rocca
Frontiers in Chemistry|November 14, 2024
<i>In-situ</i> FTIR spectroscopy of epoxy resin degradation: kinetics and mechanismsMarianna Pannico, Giuseppe Mensitieri, Pellegrino Musto
Pharmaceuticals (Basel, Switzerland)|January 12, 2021
Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the ShelfGregorio Barilà, Rita Rizzi, Renato Zambello, et al.
Pageof 40

Showing results (1-10 of 392) with videos related to

Sort By:
Pageof 40
Clinical Lymphoma|January 11, 2003
Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple associationPellegrino Musto
Leukemia Research|April 28, 2004
Thalidomide therapy for myelodysplastic syndromes: current status and future perspectivesPellegrino Musto
Expert Opinion on Investigational Drugs|August 24, 2007
Melphalan: old and new uses of a still master drug for multiple myelomaPellegrino Musto, Fiorella D'Auria
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|February 8, 2024
A stable and sensitive 2D SERS sensor for bioanalytical applicationsMarianna Pannico, Pellegrino Musto
Expert Opinion on Biological Therapy|March 10, 2011
The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disordersPellegrino Musto, Fiorella D'Auria
Expert Review of Hematology|June 9, 2016
Are maintenance and continuous therapies indicated for every patient with multiple myeloma?Pellegrino Musto, Vittorio Montefusco
Expert Review of Hematology|March 11, 2020
Monoclonal antibodies in relapsed/refractory myeloma: updated evidence from clinical trials, real-life studies, and meta-analysesPellegrino Musto, Francesco La Rocca
Expert Review of Hematology|April 16, 2020
Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidencePellegrino Musto, Francesco La Rocca
Frontiers in Chemistry|November 14, 2024
<i>In-situ</i> FTIR spectroscopy of epoxy resin degradation: kinetics and mechanismsMarianna Pannico, Giuseppe Mensitieri, Pellegrino Musto
Pharmaceuticals (Basel, Switzerland)|January 12, 2021
Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the ShelfGregorio Barilà, Rita Rizzi, Renato Zambello, et al.
Pageof 40